期刊文献+

抗线粒体抗体与原发性胆汁性肝硬化 被引量:5

原文传递
导出
出处 《中华风湿病学杂志》 CAS CSCD 2005年第8期506-508,共3页 Chinese Journal of Rheumatology
  • 相关文献

参考文献24

  • 1Walker JG, Daniach D, Roitt IM, et al, Serological tests in diagnosis of primary biliary cirrhosis. Lancet, 1965, 39: 827-831.
  • 2Berg PA. Muscatello U, Home RW, et al. Mitoehondrial antibodies in primary biliary cirrhosis Ⅱ: the complement fixing antigen as a component of mitochondrial inner membranes. Br J Exp Pathol, 1969, 50: 200-208.
  • 3Gershwin ME, Mackay IR, Sturgess A, et al, Identification and specificity of a cDNA encoding the 70 000 mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol, 1987, 138:3525-3531.
  • 4Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimito-chondrial autoantibodies in immunofluorescent AMA2 negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology, 2001, 34: 243-248.
  • 5Haydon GH, Neuberger J.PBC: an infectious disease. Gut, 2000,47: 586-588.
  • 6Long SA, Quan C, van de Water J, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase:connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001, 167: 2956-2963.
  • 7Reynoso-Paz S, Coppel RL, Mackay IR, et al. The immunobiology of bile and biliary epithelium. Hepatology, 1999, 30:351-357.
  • 8Floreani A, Baragiotta A, Pizzuti D, et al. Mucosal IgA defect in primary biliary cirrhosis. Am J Gastroenterol. 2002, 97:508-510.
  • 9Masuda J, Omagari K, Ohba K, et al. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxoacid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sei, 2003, 48: 932-938.
  • 10Matsumura S, van de Water J, Leung P, et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology, 2004, 39: 1415-1422.

同被引文献41

  • 1牛英,王志光,俞岚.54例原发性胆汁性肝硬化临床分析[J].云南医药,2007,28(1):45-46. 被引量:4
  • 2Metcalf JV, Mitchison HC, Palmer J, et al. Natural history of early primary biliary cirrhosis. Lancet,1996, 348: 1399-1402.
  • 3Bach N, Odin JA. Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med, 2003, 70: 242-250.
  • 4Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet, 2003, 362: 53-61.
  • 5Prince MI, Chetwynd A, Craig WL, et al. Asymptomatie primary biliary cirrhosis: clinieal features, prognosis, and symptom progression in a large population based cohort. Gut, 2004, 53: 865-870.
  • 6Shigematsu H, Shimoda S, Nakamura M, et al. Fine specificity of T cells reactive to human PDC-E2 163-172 peptide, the immuno-dominant auto-antigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial auto-antigens. Hepatology, 2000, 32: 901-909.
  • 7Matsumura S, Kita H, He XS, et al. Comprehensive mapping of HLA-A0201-restricted CD8^+ T-cell epitopes on PDC-E2 in primary biliary cirrhosis. Hepatology, 2002, 32:1125-1134.
  • 8Albanis E, Safadi R, Friedman SL. Treatment of hepatic fibrosis: almost there. Curr Gastroenterol Rep, 2003, 5: 48-56.
  • 9Kamihira T, Shimoda S, Harada K, et al. Distinct co-stimulation dependent and independent auto-reactive T-cell clones in primary biliary cirrhosis. Gastroenterology, 2003, 125: 1379-1387.
  • 10Heatheote El. Management of primary biliary cirrhosis, the american association for the study of liver diseases practice guidelines. Hepatology, 2000, 31:1005-1013.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部